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Background
Sirtuins are a family of NAD
+-dependent deacetylase,
deacylase, and/or mono-ADP ribosyltransferase enzymes
involved in regulation of many biological processes.
Mammals contain seven sirtuins, three of which are loca-
lized to the mitochondria (SIRT3-5). SIRT3 has been
shown to be the major mitochondrial deacetylase that
regulates metabolic enzymes and promotes oxidative
metabolism and energy production. Loss of one copy of
the SIRT3 gene is observed in various human cancers.
Thus, we examined the role of SIRT3 in regulating meta-
bolism in cancer cells.
Materials and methods
We have examined glucose uptake and lactate production
in a variety of human cancer cell lines, as well as wild-type
and SIRT3 null mouse embryonic fibroblasts (MEFs). In
addition, we have utilized steady-state metabolomics to
determine the metabolic profile of wild-type and SIRT3
null MEFs. Lastly, we utilized a combination of techniques,
including quantitative RT-PCR and Western blotting, to
examine the mechanism by which SIRT3 regulates cancer
cell metabolism.
Results
Our data show that loss of SIRT3 increases glucose
uptake and lactate production. Based on these and pre-
vious results from our laboratory, SIRT3 functions as a
tumor suppressor to repress the Warburg effect by
decreasing reactive oxygen species and destabilizing
HIF1a [1]. We are currently examining other metabolic
pathways important to cancert h a tm a yb er e g u l a t e db y
SIRT3.
Conclusions
In conclusion, we show that loss of SIRT3 results in
increased glycolysis, which is the metabolic reprogram-
ming observed in some cancer cells and is also known as
the Warburg effect.
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